Icon ICLR
NASDAQ ICLR
$169.68 -4.26 (-2.45%)
At close: Sep 17, 2026 · 4:00 PM EDT

Icon (ICLR) Total Non-Current Liabilities (2009 - 2026)

Icon's (ICLR) quarterly Total Non-Current Liabilities came in at $6.9 billion in Q2 2026, little changed year-over-year from $7.0 billion in Q2 2025, and little changed quarter-over-quarter from $6.9 billion in Q1 2026.

Analysis

Icon (ICLR) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Icon (ICLR) has reported Total Non-Current Liabilities for 18 consecutive years, with $6.9 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities changed 0.08% year-over-year to $6.9 billion in Q2 2026; TTM through Jun 2026 was $6.9 billion, a 0.08% change from a year earlier, with the FY2025 full-year figure at $3.8 billion, down 14.78% from the prior year.
  • Total Non-Current Liabilities was $6.9 billion for Q2 2026 at Icon, roughly flat from $6.9 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $9.1 billion in Q1 2022 and troughed at $3.8 billion in Q4 2025.
  • A 5-year average of $7.1 billion and a median of $7.2 billion in 2024 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities soared 478.58% in 2022 and slumped 47.12% in 2024, its largest moves.
  • Over 5 years, Total Non-Current Liabilities stood at $5.8 billion in 2022, then surged by 34.61% to $7.7 billion in 2023, then slumped by 42.84% to $4.4 billion in 2024, then retreated by 14.78% to $3.8 billion in 2025, then jumped by 83.98% to $6.9 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $6.9 billion (Q2 2026), $6.9 billion (Q1 2026), and $3.8 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 22.94 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 1.56 Bn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 6.94 Bn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 4.24 Bn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 2.15 Bn
6 Evotec SE 574.75 Mn 148.87 Mn - 30.49 Mn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 553.39 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 28.62 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.94 Bn
Mar 31, 2026 6.95 Bn
Dec 31, 2025 3.77 Bn
Sep 30, 2025 7.07 Bn
Jun 30, 2025 6.95 Bn
Mar 31, 2025 7.14 Bn
Dec 31, 2024 4.43 Bn
Sep 30, 2024 7.39 Bn
Jun 30, 2024 7.34 Bn
Mar 31, 2024 4.54 Bn
Dec 31, 2023 7.75 Bn
Sep 30, 2023 8.03 Bn
Jun 30, 2023 8.27 Bn
Mar 31, 2023 8.59 Bn
Dec 31, 2022 5.76 Bn
Sep 30, 2022 8.85 Bn
Jun 30, 2022 8.85 Bn
Mar 31, 2022 9.06 Bn
Dec 31, 2021 6.66 Bn
Sep 30, 2021 9.61 Bn